DHH S.p.A, the Technology sector company, was revisited by a Wall Street analyst on November 24. Analyst Michele Mombelli from TP ICAP MIDCAP maintained a Buy rating on the stock and has a €30.50 price target.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Michele Mombelli has given his Buy rating due to a combination of factors that highlight DHH S.p.A’s potential for growth and innovation. The company is actively developing new products, such as Regolo.Ai, which is expected to drive future revenue through its AI inference platform. Although currently offered as a free service, the commercialization of Regolo.Ai is anticipated to attract clients interested in open-source LLMs and public commercial AI solutions.
Additionally, DHH’s strategic M&A activities are designed to enhance margins, despite short-term fluctuations. The company is also focusing on organic growth, aiming to surpass the current 8% rate, with expectations that AI advancements will become more visible soon. Furthermore, DHH’s GPU business offers competitive leasing prices and good margins, particularly appealing to pharmaceutical clients. These strategic initiatives and market positioning underpin Mombelli’s positive outlook on DHH’s stock.
According to TipRanks, Mombelli is an analyst with an average return of -7.0% and a 20.00% success rate.
In another report released yesterday, Intermonte also maintained a Buy rating on the stock with a €31.00 price target.